192 related articles for article (PubMed ID: 25007361)
1. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P;
J Drugs Dermatol; 2014 Jul; 13(7):791-8. PubMed ID: 25007361
[TBL] [Abstract][Full Text] [Related]
2. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial.
Khemis A; Duteil L; Coudert AC; Tillet Y; Dereure O; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1240-6. PubMed ID: 21981375
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
Baker D; Eisen D
Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
[TBL] [Abstract][Full Text] [Related]
5. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir Lauriad(®): a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis.
Downing C; Moayyad J; Tamirisa A; Tyring S
Expert Rev Anti Infect Ther; 2014 Mar; 12(3):283-7. PubMed ID: 24456534
[TBL] [Abstract][Full Text] [Related]
7. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
Busch R; Graubaum HJ; Gruenwald J; Faergemann J
Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
12. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
14. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
15. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
Spruance SL; Bodsworth N; Resnick H; Conant M; Oeuvray C; Gao J; Hamed K
J Am Acad Dermatol; 2006 Jul; 55(1):47-53. PubMed ID: 16781291
[TBL] [Abstract][Full Text] [Related]
16. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
17. Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage) : Randomized, controlled double-blind study.
Jautová J; Zelenková H; Drotarová K; Nejdková A; Grünwaldová B; Hladiková M
Wien Med Wochenschr; 2019 May; 169(7-8):193-201. PubMed ID: 30406509
[TBL] [Abstract][Full Text] [Related]
18. A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
Kawashima M; Watanabe D; Fujio K; Komazaki H
J Dermatol; 2023 Mar; 50(3):311-318. PubMed ID: 36353762
[TBL] [Abstract][Full Text] [Related]
19. No significant analgesic benefit of adding lidocaine 2% to aciclovir 5% cream as treatment of episodes of herpes labialis.
Bodsworth NJ; Bayerl C; Cunningham A; Silny W
Herpes; 2003 Aug; 10(2):53-4. PubMed ID: 14577955
[No Abstract] [Full Text] [Related]
20. Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial.
Khemis A; Duteil L; Tillet Y; Dereure O; Ortonne JP
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1158-64. PubMed ID: 24010876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]